Researchers' Work from Changchun University of Chinese Medicine Focuses on Liver Cancer (New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment).

A recent study conducted by researchers at Changchun University of Chinese Medicine focuses on liver cancer, which is one of the most common primary neoplasms of the liver and a leading cause of cancer-related deaths. The study examines the role of chemokines in the tumor microenvironment (TME) of hepatocellular carcinoma (HCC) and their interrelationship with hepatocarcinogenesis and progression. The researchers discuss the potential therapeutic strategies targeting tumor-promoting chemokines and the induction/release of beneficial chemokines, highlighting the value of natural products in modulating chemokines and their receptors for the treatment of HCC. The study provides a theoretical basis for the treatment of HCC and may serve as an important reference for new drug development and clinical research. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)